Ago Research Gmbh
Clinical trials sponsored by Ago Research Gmbh, explained in plain language.
-
New drug combo offers hope for Hard-to-Treat vulvar cancer
Disease control Recruiting nowThis study tests whether two drugs, pembrolizumab and lenvatinib, can shrink or control advanced vulvar cancer that has returned or spread and cannot be treated with surgery or radiation. About 42 women with this type of cancer will receive the drug combination. The goal is to se…
Phase: PHASE2 • Sponsor: AGO Research GmbH • Aim: Disease control
Last updated May 26, 2026 11:42 UTC
-
New drug combo could boost ovarian cancer surgery success
Disease control Recruiting nowThis study is for people with advanced ovarian cancer who are scheduled for surgery. It tests whether taking a drug called olaparib alone or with another drug called durvalumab for a short time before surgery is safe and practical. The goal is to see if this approach can be done …
Phase: PHASE2 • Sponsor: AGO Research GmbH • Aim: Disease control
Last updated May 15, 2026 12:01 UTC